Purple heart plant leaves extract-mediated silver nanoparticle synthesis: Optimization by Box-Behnken design MS Hasnain, MN Javed, MS Alam, P Rishishwar, S Rishishwar, S Ali, ... Materials Science and Engineering: C 99, 1105-1114, 2019 | 174 | 2019 |
Lipid-based nanoformulations in the treatment of neurological disorders GEBGMA Faheem Hyder Pottoo, Shrestha Sharma, Md. Noushad Javed, Md. Abul ... Drug Metabolism Reviews, 1-20, 2020 | 95* | 2020 |
Gum ghatti mediated, one pot green synthesis of optimized gold nanoparticles: Investigation of process-variables impact using Box-Behnken based statistical design MS Alam, A Garg, FH Pottoo, MK Saifullah, AI Tareq, O Manzoor, ... International journal of biological macromolecules 104, 758-767, 2017 | 88 | 2017 |
The synergistic effect of raloxifene, fluoxetine, and bromocriptine protects against pilocarpine-induced status epilepticus and temporal lobe epilepsy FH Pottoo, N Tabassum, MN Javed, S Nigar, R Rasheed, A Khan, ... Molecular neurobiology 56, 1233-1247, 2019 | 82 | 2019 |
Bioinspired nanocomposites: applications in disease diagnosis and treatment S Mishra, S Sharma, MN Javed, FH Pottoo, MA Barkat, MS Alam, M Amir, ... Pharmaceutical nanotechnology 7 (3), 206-219, 2019 | 77 | 2019 |
Pharmaceutical quality by design: principles and applications S Beg, MS Hasnain Academic Press, 2019 | 68 | 2019 |
Estrogen and serotonin: complexity of interactions and implications for epileptic seizures and epileptogenesis FH Pottoo, MN Javed, MA Barkat, MS Alam, JA Nowshehri, DM Alshayban, ... Current Neuropharmacology 17 (3), 214-231, 2019 | 68 | 2019 |
QbD approached comparison of reaction mechanism in microwave synthesized gold nanoparticles and their superior catalytic role against hazardous nirto‐dye F MD Sabir Alam, MD Noushad Javed, Fahim Hyder Putto, Arun Garg, Mohammad ... applied organometallic chemistry, 2019 | 56 | 2019 |
QbD applications for the development of nanopharmaceutical products MN Javed, MS Alam, A Waziri, FH Pottoo, AK Yadav, MS Hasnain, ... Pharmaceutical quality by design, 229-253, 2019 | 56 | 2019 |
Brain-Derived Neurotropic Factor in Neurodegenerative Disorders, MSAFH Abdallah Mohammad Ibrahim, Lalita Chauhan, Aditi Bhardwaj, Anjali ... biomedicines 10 (5), 1143 (1-18), 2022 | 52 | 2022 |
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice FH Pottoo, N Tabassum, MN Javed, S Nigar, S Sharma, MA Barkat, ... European Journal of Pharmaceutical Sciences 146, 105261, 2020 | 43 | 2020 |
Recent Advancement in Clinical Application of Nanotechnological Approached Targeted Delivery of Herbal Drugs FHP Md Noushad Javed, Ekta Singh Dahiya, Abdallah Mohammad Ibrahim, Md ... Nanophytomedicine 1 (https://link.springer.com/chapter/10.100), 151-172, 2020 | 32* | 2020 |
Review on Natural Bioactive Products as Radioprotective Therapeutics :Present & Past Perspective, AMS Raj Seema, Manchanda Romila, Bhandari Meena* Current Pharmaceutical Biotechnology 1 (2022; 23() .), 1873-4316, 2022 | 31* | 2022 |
Lipid nanocarriers for neurotherapeutics: introduction, challenges, blood-brain barrier, and promises of delivery approaches M Aslam, MN Javed, HH Deeb, MK Nicola, M Mirza, MS Alam, MH Akhtar, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 29 | 2022 |
Carbon allotropes-based nanodevices: graphene in biomedical applications S Singhal, M Gupta, MS Alam, MN Javed, JR Ansari Nanotechnology, 241-269, 2022 | 28 | 2022 |
Probiotics for the Chemoprotective Role Against the Toxic Effect of Cancer Chemotherapy MSA Aafrin Waziri, Charu Bharti, Mohammed Aslam, Parween Jamil, Aamir Mirza ... Anticancer Agents Med Chem ., 2021 | 26* | 2021 |
Design of experiments for the development of nanoparticles, nanomaterials, and nanocomposites MN Javed, FH Pottoo, A Shamim, MS Hasnain, MS Alam Design of Experiments for Pharmaceutical Product Development: Volume II …, 2021 | 26 | 2021 |
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases MSAAKV Namrata Kumari, Nagarjuna Daram CNS & Neurological Disorders - Drug Targets 1 (1), 10.2174 …, 2022 | 25* | 2022 |
C-Dot nanoparticulated devices for biomedical applications R Kumar, G Dhamija, JR Ansari, MN Javed, MS Alam Nanotechnology, 271-299, 2022 | 22 | 2022 |
Cationic nanoparticles for treatment of neurological diseases MN Javed, MH Akhter, M Taleuzzaman, M Faiyazudin, MS Alam Fundamentals of Bionanomaterials, 273-292, 2022 | 22 | 2022 |